Please use this identifier to cite or link to this item: https://hdl.handle.net/1/2096
Full metadata record
DC FieldValueLanguage
dc.contributor.authorBack, Michael F-
dc.contributor.otherAng, E.L.L.-
dc.contributor.otherNg, W.H.-
dc.contributor.otherSee, S.J.-
dc.contributor.otherLim, C.C.T.-
dc.contributor.otherChan, S.P.-
dc.contributor.otherYeo, T.T.-
dc.date.accessioned2022-02-17T02:55:55Z-
dc.date.available2022-02-17T02:55:55Z-
dc.date.issued2007-05-
dc.identifier.citationVolume 36, Issue 5, pp. 338 - 342en
dc.identifier.urihttps://elibrary.cclhd.health.nsw.gov.au/cclhdjspui/handle/1/2096-
dc.subjectCanceren
dc.subjectDrug Therapyen
dc.titleImproved median survival for glioblastoma multiforme following introduction of adjuvant temozolomide chemotherapyen
dc.typeJournal Articleen
dc.description.pubmedurihttps://pubmed.ncbi.nlm.nih.gov/17549280/en
dc.identifier.journaltitleAnnals of the Academy of Medicine Singaporeen
dc.relation.orcidhttp://orcid.org/0000-0003-2363-8333en
dc.originaltypeTexten
item.grantfulltextnone-
item.openairecristypehttp://purl.org/coar/resource_type/c_18cf-
item.cerifentitytypePublications-
item.openairetypeJournal Article-
item.fulltextNo Fulltext-
Appears in Collections:Oncology / Cancer
Show simple item record

Google ScholarTM

Check


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.